Gene Query: CENPC

Dataset Description Geneva Score
Human cell line and subcutaneous tumor 14.83
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 14.73
RNA sequencing of matched nephrectomy samples [RNA-seq] 14.73
Global Mapping of Human RNA-RNA Interactions 13.95
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 13.75
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.85
U2AF1 mutations alter splice site recognition in hematological malignancies 11.68
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 11.63
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.51
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 10.57
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 10.31
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 10.21
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.12
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.07
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 8.87
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.86
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 8.83
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 8.83
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.81
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 8.76
Mapping interactions for the TNIP2 hub protein 8.5
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 7.99
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 7.94
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.92
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.9
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.86
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.79
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.79
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 7.54
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.52
CROP-Seq in Primary Human T Cells 7.39
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 7.26
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 7.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 7.16
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.13
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.13
Targeted enhancer activation by a subunit of the integrator complex 7.09
Genome-wide discovery of human splicing branchpoints 6.99
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.97
LncRNA expression profiling of ischemic stroke patients 6.72
Gene expression profile of human iPSC-derived nephron progenitor cells 6.62
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.62
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 6.6
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 6.55
Zone dependent distinctive gene expression profile of the normal human liver tissue 6.55
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 6.54
Next generation sequencing of small RNAs isolated from exosomes in human semen 6.48
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 6.42
RNA-seq data from human lymphoma cell lines 6.41
ChIP-seq and RNA-seq from human lymphoma cell lines 6.41
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 6.4
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.36
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.29
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 6.14
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 6.13
RNAseq Analysis in glioblastoma cells treated with Mepazine 6.06
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.04
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.94
Gene expression in PANC1 cells treated with Rakicidin 5.92
The pause-initiation limit restricts transcription activation in human cells 5.87
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.87
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.86
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.85
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.81
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.79
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 5.74
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 5.73
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 5.69
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.68
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.61
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 5.59
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 5.58
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.53
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.53
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 5.51
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 5.5
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.5
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.5
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.39
Unique features and clinical importance of acute alloreactive immune responses 5.33
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.32
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.23
TOP2B disturbed the quality of human oocytes with advanced maternal age 5.22
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 5.22
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 5.2
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 5.17
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 5.11
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.09
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 5.04
The evolution of N6-methyladenosine in primates 5.0
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.98
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.97
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.97
Zika infected neural stem cells 4.87
Transcriptome analysis of Zika infected neural stem cells 4.87
Depicting early human development and germ cell origin with porcine embryos 4.85
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.82
Regulation of protein translation during mitosis 4.82
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.8
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.76
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 4.75
Seletive inhibition of CDK9 in DLBCL cell lines 4.64
Selective suppression of endothelial cytokine production by progesterone receptor 4.55
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 4.55
Transcriptional profiling of LS1034 cells treated with tepoxalin 4.54
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 4.53
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.52
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.52
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.49
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 4.49
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 4.45
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.45
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.41
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.41
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 4.4
mRNA expression profile of Lymphocytes 4.38
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 4.37
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 4.37
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 4.34
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 4.34
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.33
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 4.32
Impact of dieldrin on transcription in Jurkat T cells 4.29
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 4.26
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.25
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.22
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 4.19
RNA-seq analysis to identify the genes regulated by p53-SET interplay 4.14
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.13
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.13
Single-cell analysis of human kidney organoids 4.1
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.07
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.06
MYC dependent mRNA translation shapes gene expression and cell biology 4.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 4.03
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.01
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.99
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 3.98
Fibroblasts in cholesteatoma activate osteoclasts. 3.93
LncRNA-GAS5 negative regulation of YAP-target genes expression 3.91
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.89
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.89
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 3.87
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.86
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.86
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 3.82
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 3.82
Expression and functions of long noncoding RNAs during human T helper cell differentiation 3.81
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 3.77
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.75
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.75
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.73
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.71
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.71
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.71
Identification of renal resident macrophages across species 3.67
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.65
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 3.65
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 3.63
RNA-Seq from human ILC transitional populations 3.63
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 3.61
FBXW7 modulates stress response by post-translational modification of HSF1 3.59
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.59
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 3.59
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 3.56
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.55
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.52
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.52
TGF-β regulation of miRNA expression in pancreatic cancer 3.51
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.5
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 3.49
Knockdown of ADNP in HCT116 colon cancer cells 3.48
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 3.47
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.45
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.44
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 3.43
Expression profiling of etoposide-induced senescent cells 3.42
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 3.42
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.41
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 3.35
Landscape of H3K4me3 in human CD19 cells 3.35
Targeting MTHFD2 in Acute Myeloid Leukemia 3.34
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.32
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.28
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.28
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 3.26
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 3.26
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 3.23
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.19
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.18
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 3.18
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.17
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.15
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.15
Dynamic 3D chromosomal landscapes in acute leukemia 3.15
RNA-sequencing of formalin fixed human primary melanoma tissue 3.14
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 3.12
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 3.12
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.1
Genome-wide discovery of human splicing branchpoints [RNAse] 3.09
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 3.09
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.08
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 3.07
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.06
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.06
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 3.05
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 3.03
Gene expression signatures of innate lymphoid cells from human blood 3.03
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.02
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.02
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.99
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.99
MYCL and EP400 are required for Max and MCPyV mediated gene activation 2.98
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 2.97
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.96
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.96
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.94
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.92
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.92
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.91
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.87
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.85
MeRIP-seq for heat shock in B-cell lymphoma cells 2.85
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.78
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.76
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.76
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 2.75
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.74
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.74
Expression patterns in chronic thromboembolic pulmonary hypertension 2.73
MAIT cell RNA sequencing 2.72
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.71
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.71
nELAVL HITS-CLIP in Alzheimer's Disease patients 2.71
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.67
Transcriptome-wide response to synthetic chromatin protein PcTF 2.65
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.63
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.6
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.6
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.6
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 2.58
Identification of Atrial Fibrillation associated genes and functional non-coding variants 2.57
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 2.57
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 2.57
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.55
Common inflammatory pathways between NEC and Crohn's disease 2.54
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 2.52
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.51
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 2.51
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.5
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 2.5
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.49
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.49
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.48
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 2.44
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 2.44
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.43
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 2.43
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.39
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.34
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.33
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.33
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.32
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.29
scRNASeq analysis of cycling cardiomyocytes 2.28
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 2.27
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 2.26
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.25
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.23
RNA polymerase in pre-B-ALL cell lines 2.23
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.23
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.22
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.22
IMP3 regulated gene expression in breast cancer cells 2.19
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 2.18
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 2.17
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 2.17
DRB/GRO-Seq -/+ UV 2.16
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.15
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.15
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.14
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.14
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.14
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.14
Gene expression profiling of leukemia cells following asparagine depletion 2.1
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.07
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 2.04
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.01
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.01
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.0
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.0
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.99
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.98
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.96
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 1.94
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.94
KSDM1b Role in Ewing Sarcoma 1.93
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.92
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.92
SRSF2 mutations impair hematopoiesis and alter exon recognition 1.92
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.9
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 1.89
Human Treg IL-12 stimulation 1.87
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.86
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.86
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.86
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.86
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.85
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.85
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.83
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.83
Single-Cell Genotyping of Transcriptomes 1.8
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.8
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 1.79
Transcriptomes of oxLDL exposed trained monocytes 1.75
oxLDL exposed trained monocytes 1.75
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 1.75
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 1.75
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 1.74
The age and genomic integrity of neurons after cortical stroke in humans 1.74
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.74
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.74
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.74
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.72
High-resolution comparative analysis of great ape genomes 1.71
Effect of PRDM11 depletion in U2932 cells 1.69
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 1.65
K562 polyA RNA-Seq 1.63
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.59
TAF1 is critical for AE driven leukemogenesis 1.59
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.59
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.57
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.57
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 1.57
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.56
Transcriptomic profiling of human peripheral blood-derived mast cells 1.56
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.56
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.55
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 1.55
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 1.54
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 1.54
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 1.52
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 1.52
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.51
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.51
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.51
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.51
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.49
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.49
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.46
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.46
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.46
Identification of long noncoding RNAs in T-ALL cell lines 1.43
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.43
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.43
Polarized B -cell functions 1.4
4sU-seq of HFF exposed to salt and heat stress 1.4
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.37
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.37
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 1.37
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.37
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.35
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.35
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.35
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.34
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.34
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.34
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.33
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.33
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.31
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.31
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.31
RNA-seq data 1.3
Total RNA-Seq data from leukemic patients with complex structural variants 1.28
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.27
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.25
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.25
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.23
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 1.22
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.2
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.16
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.16
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 1.15
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.15
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.14
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.13
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.11
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.1
RNA-seq analysis of control and Myc-induced U2OS cells 1.09
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 1.09
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.07
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.07
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.07
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 1.07
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 1.04
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.04
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.02
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.01
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.98
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.97
Human Treg IFNg/IL-10 subpopulations 0.96
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.95
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.95
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 0.94
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.94
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.93
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.93
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.92
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.92
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.91
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.91
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.85
RNA-seq of primary patient AML samples 0.84
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.82
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.82
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.79
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.79
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.78
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 0.78
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.73
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.72
Global transcriptome analysis of WT versus HEB-/- hESCs 0.72
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.72
Transcriptional landscape changes during human embryonic stem cell derivation 0.7
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.69
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.68
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.66
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.64
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.64
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.61
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 0.61
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 0.61
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.6
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.59
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.56
Dermal endothelial cells of type 2 diabetic patients 0.53
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.53
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.53
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.52
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.51
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.5
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.46
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.46
RNA-seq of CD33 KO and control HSPCs 0.45
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 0.44
SNHG5 siRNA knock down in HCT116 cells 0.43
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.41
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.41
Leucegene: AML sequencing (part 6) 0.41
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.38
RNA seq comparison between scrambled and shGRP78 cells 0.37
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.36
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.35
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.34
Aging-associated patterns in the expression of human endogenous retroviruses 0.34
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.31
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.31
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.31
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.3
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.29
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.28
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.26
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.25
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.25
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.25
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.25
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.23
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.23
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.22
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.21
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.2
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.2
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.16
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.16
RNA-seq of SCLC PDX models treated with EP 0.15
Gene expression changes due to PARP knockdown in human cells 0.14
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.11
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.11
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.11
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.11
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.11
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.1
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.1
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.1
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.09
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.08
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.08
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.07
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.07
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.04
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.02
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.02
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.02
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation